BAY 55-9837



BAY 55-9837

H1HH1S2SS2D3DD3A4AA4V5VV5F6FF6T7TT7D8DD8N9NN9Y10YY10T11TT11R12RR12L13LL13R14RR14K15KK15Q16QQ16V17VV17A18AA18A19AA19K20KK20K21KK21Y22YY22L23LL23Q24QQ24S25SS25I26II26K27KK27N28NN28K29KK29R30RR30Y31YY31

SMILES None
InChIKey XALJYDFLMDKOLY-ZBLLYJRDSA-N
Sequence HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


Bioactivities

BAY 55-9837

H1HH1S2SS2D3DD3A4AA4V5VV5F6FF6T7TT7D8DD8N9NN9Y10YY10T11TT11R12RR12L13LL13R14RR14K15KK15Q16QQ16V17VV17A18AA18A19AA19K20KK20K21KK21Y22YY22L23LL23Q24QQ24S25SS25I26II26K27KK27N28NN28K29KK29R30RR30Y31YY31

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.